Visual outcomes of polypoidal choroidal vasculopathy treated with intravitreal ranibizumab with or without photodynamic therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|96|2|e254-e255

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.96, Iss.2, 2018-03, pp. : e254-e255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e258-e259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polypoidal choroidal vasculopathy treatment options: A meta‐analysis

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optical coherence tomography in polypoidal choroidal vasculopathy disease

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 9, 2015-12 ,pp. : 779-781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of aflibercept for polypoidal choroidal vasculopathy in Caucasians

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 1, 2018-02 ,pp. : e94-e95

John Wiley & Sons Inc

Access to resources Recommend Favorite